Permanently Discontinued

JAMP-TOBRAMYCIN

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is JAMP-TOBRAMYCIN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that JAMP-TOBRAMYCIN 40MG has been permanently discontinued (last updated December 19, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is JAMP-TOBRAMYCIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 0 same form & route

Affected strength40MG

Report last updated2018-12-19

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

TOBRAMYCIN INJECTION, USP

FRESENIUS KABI CANADA LTD

40MG · DIN 02230640

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBRAMYCIN FOR INJECTION

FRESENIUS KABI CANADA LTD

1.2G · DIN 00533688

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBRAMYCIN INJECTION USP

SANDOZ CANADA INCORPORATED

10MG · DIN 02241209

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBREX

NOVARTIS PHARMACEUTICALS CANADA INC

0.3% · DIN 00513962

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TOBI

BGP PHARMA ULC

300MG · DIN 02239630

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

SANDOZ TOBRAMYCIN

SANDOZ CANADA INCORPORATED

0.3% · DIN 02241755

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02420287

Strength

40MG

Dosage Form

LIQUID

Route

INTRAMUSCULAR INTRAVENOUS

Active Ingredient

TOBRAMYCIN

See all TOBRAMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2018-12-19

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225